Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major

NCT03171831 is registered in ClinicalTrials.gov with First Affiliated Hospital of Guangxi Medical University as lead sponsor.

NCT NCT03171831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03171831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major
Lead sponsor
First Affiliated Hospital of Guangxi Medical University
Phase
Phase 4
Overall status
Unknown status
Start date
April 1, 2017
Completion date
April 1, 2022
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thalassemia major